Clinical Trial Update: Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting normative benchmarks for cognitive testing and Alzheimer's disease imaging biomarkers in young adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED